KSCM
MRK icon

Kamunting Street Capital Management’s Merck MRK Stock Holding History

Kamunting Street Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-43,000
Closed -$3.34M – 69
2021
Q2 		$3.34M Buy
+43,000
New +$3.2M 1.35% 26

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Kamunting Street Capital Management's MRK Position: Q4 2025 in Review

Kamunting Street Capital Management sold out of Merck (MRK) in Q4 2025, closing a stake of 50,000 shares — an estimated $4.2M sold.

Kamunting Street Capital Management first reported a position in MRK in Q3 2017 and held it in 8 quarters. The position peaked at $4.95M in Q4 2017. 3,657 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

  • Kamunting Street Capital Management reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
  • Kamunting Street Capital Management sold 50,000 Merck shares in Q4 2025, an estimated $4.2M.
  • Kamunting Street Capital Management first reported a position in Merck in Q3 2017 and held it in 8 quarters.
  • Kamunting Street Capital Management's Merck position peaked at $4.95M in Q4 2017.
  • 3,657 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on Kamunting Street Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.